4300 DNA Analysis System from LI-COR Biosciences
Mouse Anti-Human SCGB3A2 Monoclonal Antibody, Unconjugated, Clone 1B2 from Abnova Corporation
Mouse Anti-Human QPCT Polyclonal Antibody, Unconjugated from Abnova Corporation
...S are multi-functional mixing devices. Stepping mo...solid, heavy-duty durable shaker to provide a unif...ture. Regulated action scale for all modes. Microp...rol time, continuous time, action scale and speed....
Biology Products:...l component of the human immunodeficiency virus (H...g cells consists of functionally-specialized layer...iversity of California San Diego (UCSD) Antiviral ...LoS Computational Biology. , The unprecedented ... far foiled the best efforts to eradicate the glob...
...get the moo-moo here and quack-quack there. Farmer...za. , And water may be the drop in the bucket tha...al interests, according to research by the Texas A...pplying less water to certain vegetables in the fa...ls, or nutrients, for which consumers may one day ...
... Conn. The gigantic fossil claw of an 390 million... shows that ancient arthropods spiders, insects, ...their modern-day counterparts. , Imagine an eight...ctoral associate in the Department of Geology and...online in Royal Society Biology Letters. The claw ...
Other Biology News:Old McDonald had a phytochemical 2Old McDonald had a phytochemical 3(Date:11/24/2009)... , REYKJAVIK, Iceland, Novem...Inc. (Nasdaq: DCGN ) today announced the approval ...ruptcy Court for the District of Delaware,(the "Ba...ry petition for,relief under Chapter 11 of the Uni...rt. , The orders issued by the Bankruptcy...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asi... Food & Drug Administration (SFDA) has approve...or its oral insulin project,(Nodlin), an innovativ...approval allows Biolaxy to initiate its first phas...der characteristic of high blood glucose and poor,...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-F... ARNA ) announced today that the company is sche...Health Care Conference on December 1, 2009 at 11:3...e New York Palace Hotel in New York City. Jack Lie...is scheduled to provide an overview of the company...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3